Search All News
OPTIC provides researchers access to a broad range of in vivo imaging technologies that can help advance our understanding of how cancer progresses, and accelerate translational research.
The MCSR at the HICCC provides a wide range of technology platforms and services–from classical cytogenetics and high throughput imaging analyses to sequence-based assessment of DNA damage and repair.
Development of transgenic and genetically modified mouse models continue to be the most common in vivo models for studying human disease.
The Proteomics and Macromolecular Crystallography Shared Resource (PMCSR) provides researchers cutting-edge proteomic and structural biology technologies and analysis.
- May 18, 2020
With next-generation sequencing, it possible not only to look at individual genomes, but also to rapidly compare genetic sequences among multiple genomes.
- May 11, 2020
The Single Cell Analysis shared resource provides researchers with experimental and comprehensive computational support for single-cell RNA-Sequencing and single-cell ATAC-Sequencing.
- April 27, 2020
The Flow Cytometry Shared Resource at the HICCC supports a wide variety of studies related to cancer biology, functional genomics and tumor immunology using the newest techniques.
- April 24, 2020
The High Throughput Screening shared resource is equipped with state-of-the-art instrumentation, robotic automation, and software for running high-throughput screens using assay technologies.
- April 20, 2020
Aris Floratos, PhD, Director of the Biomedical Informatics Shared Resource discusses new technologies offered for large-scale datasets.
- April 13, 2020
The Molecular Pathology Shared Resource (MPSR) is a comprehensive service for researchers and scientists conducting cutting-edge experimental, basic science, and translational research at the HICCC.